{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T03:23:59Z","timestamp":1789097039345,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.thromres.2025.109258","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T12:15:16Z","timestamp":1736856916000},"page":"109258","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Disparities in menstrual bleeding management during acute venous thromboembolism treatment: A review of UK practice and a call for clinical studies"],"prefix":"10.1016","volume":"247","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0696-6848","authenticated-orcid":false,"given":"Eman","family":"Hassan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J","family":"Buka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taran","family":"Nandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nkemdirim","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasir","family":"Alhamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip L.R.","family":"Nicolson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2025.109258_bb0005","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.contraception.2006.12.018","article-title":"Range of published estimates of venous thromboembolism incidence in young women","volume":"75","author":"Heinemann","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.thromres.2025.109258_bb0010","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.thromres.2017.03.013","article-title":"Oral contraception and menstrual bleeding during treatment of venous thromboembolism: expert opinion versus current practice: combined results of a systematic review, expert panel opinion and an international survey","volume":"153","author":"Klok","year":"2017","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2025.109258_bb0015","doi-asserted-by":"crossref","first-page":"e480","DOI":"10.1016\/S2352-3026(16)30111-9","article-title":"Management and outcomes of vaginal bleeding and heavy menstrual bleeding in women of reproductive age on direct oral anti-factor Xa inhibitor therapy: a case series","volume":"3","author":"Beyer-Westendorf","year":"2016","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.thromres.2025.109258_bb0020","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.thromres.2020.11.014","article-title":"V Chi, P Sochacki, OJT McCarty, MK Baldwin, AB Edelman, Heavy menstrual bleeding in women on oral anticoagulants","volume":"197","author":"BT Samuelson Bannow","year":"2021","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2025.109258_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.100072","article-title":"How do anticoagulants impact menstrual bleeding and quality of life? - the PERIOD study","volume":"7","author":"Patel","year":"2023","journal-title":"Res Pract Thromb Haemost."},{"key":"10.1016\/j.thromres.2025.109258_bb0030","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1182\/blood.2022017101","article-title":"Incidence and impact of anticoagulation-associated abnormal menstrual bleeding in women after venous thromboembolism","volume":"140","author":"de Jong","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2025.109258_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2024.102389","article-title":"Tranexamic acid for management of heavy vaginal bleeding: barriers to access and myths surrounding its use","volume":"8","author":"VanderMeulen","year":"2024","journal-title":"Res Pract Thromb Haemost."},{"key":"10.1016\/j.thromres.2025.109258_bb0040","article-title":"HaemSTAR-growing experience from a national","volume":"6","author":"Wilson","year":"2022","journal-title":"trainee-led research network, Hemasphere."},{"key":"10.1016\/j.thromres.2025.109258_bb0045","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.jtha.2024.04.002","article-title":"Management of abnormal uterine bleeding on anticoagulation: the patient-clinician perspective","volume":"22","author":"BT Samuelson Bannow","year":"2024","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109258_bb0050","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/rth2.12471","article-title":"Heavy menstrual bleeding on direct factor Xa inhibitors: rationale and design of the MEDEA study","volume":"5","author":"Hamuly\u00e1k","year":"2021","journal-title":"Res Pract Thromb Haemost."},{"key":"10.1016\/j.thromres.2025.109258_bb0055","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1111\/jth.14226","article-title":"Less abnormal uterine bleeding with dabigatran than warfarin in women treated for acute venous thromboembolism","volume":"16","author":"Huisman","year":"2018","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109258_bb0060","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/bjh.14003","article-title":"Heavy menstrual bleeding on rivaroxaban - comparison with apixaban","volume":"176","author":"Myers","year":"2017","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2025.109258_bb0065","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1055\/a-1891-8187","article-title":"Bleeding issues in women under oral anticoagulation","volume":"42","author":"Kalmanti","year":"2022","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.thromres.2025.109258_bb0070","series-title":"RAMBLE - Rivaroxaban vs. Apixaban for Heavy Menstrual Bleeding ((RAMBLE))","author":"Kline","year":"2023"},{"key":"10.1016\/j.thromres.2025.109258_bb0075","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.vph.2016.11.003","article-title":"Heavy menstrual bleeding in women treated with rivaroxaban and vitamin K antagonists and the risk of recurrent venous thromboembolism","volume":"87","author":"Bryk","year":"2016","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.thromres.2025.109258_bb0080","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1182\/blood-2015-08-665927","article-title":"Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use","volume":"127","author":"Martinelli","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2025.109258_bb0085","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/j.jtha.2024.03.014","article-title":"Hormonal contraceptive use after a first venous thrombotic event and the risk of recurrence in premenopausal women","volume":"22","author":"Verlaan","year":"2024","journal-title":"J. Thromb. Haemost."},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2025.109258_bb0090","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0049-3848(19)30357-3","article-title":"Optimal management of hormonal contraceptives after an episode of venous thromboembolism","volume":"181","author":"Klok","year":"2019","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2025.109258_bb0095","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/aogs.14110","article-title":"Thirty years of mirena: a story of innovation and change in women\u2019s healthcare","volume":"100","author":"Gemzell-Danielsson","year":"2021","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.thromres.2025.109258_bb0100","doi-asserted-by":"crossref","unstructured":"AC Bryant-Smith, A Lethaby, C Farquhar, M Hickey, Antifibrinolytics for heavy menstrual bleeding, Cochrane Database Syst. Rev. 4 (2018) Cd000249.","DOI":"10.1002\/14651858.CD000249.pub2"},{"key":"10.1016\/j.thromres.2025.109258_bb0105","doi-asserted-by":"crossref","unstructured":"M Bofill Rodriguez, S Dias, V Jordan, A Lethaby, SF Lensen, MR Wise, et al., Interventions for heavy menstrual bleeding; overview of Cochrane reviews and network meta-analysis, Cochrane Database Syst. Rev. 5 (2022) Cd013180.","DOI":"10.1002\/14651858.CD013180.pub2"},{"key":"10.1016\/j.thromres.2025.109258_bb0110","first-page":"413","article-title":"Tranexamic acid for the treatment of heavy menstrual bleeding: efficacy and safety","volume":"4","author":"Leminen","year":"2012","journal-title":"Int. J. Women\u2019s Health"},{"key":"10.1016\/j.thromres.2025.109258_bb0115","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1186\/s13054-021-03799-9","article-title":"Effect of tranexamic acid on thrombotic events and seizures in bleeding patients: a systematic review and meta-analysis","volume":"25","author":"Murao","year":"2021","journal-title":"Crit. Care"},{"key":"10.1016\/j.thromres.2025.109258_bb0120","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.thromres.2019.05.003","article-title":"Risk of venous and arterial thrombosis in non-surgical patients receiving systemic tranexamic acid: a systematic review and meta-analysis","volume":"179","author":"Chornenki","year":"2019","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2025.109258_bb0125","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0140-6736(17)30638-4","article-title":"Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial","volume":"389","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2025.109258_bb0130","series-title":"50 Landmark Papers every Trauma Surgeon Should Know","first-page":"31","article-title":"Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant hemorrhage (CRASH-2): a randomized, placebo-controlled trial","author":"Shakur","year":"2019"},{"key":"10.1016\/j.thromres.2025.109258_bb0135","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(19)32233-0","article-title":"CRASH-3 trial collaborators, effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial","volume":"394","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2025.109258_bb0140","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1056\/NEJMoa2201171","article-title":"Tranexamic acid in patients undergoing noncardiac surgery","volume":"386","author":"Devereaux","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2025.109258_bb0145","article-title":"Oral tranexamic acid and thrombosis risk in women","volume":"35","author":"Meaidi","year":"2021","journal-title":"E. Clin. Med."},{"key":"10.1016\/j.thromres.2025.109258_bb0150","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/S0140-6736(20)30848-5","article-title":"Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial","volume":"395","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2025.109258_bb0155","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.thromres.2024.01.009","article-title":"TRanEXamic acid to decrease heavy menstrual bleeding in individuals anticoagulated for venous thromboembolism (T-REX HMB): health care practitioner survey","volume":"235","author":"Abdulrehman","year":"2024","journal-title":"Thromb. Res."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825000076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825000076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T14:26:12Z","timestamp":1777472772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384825000076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":31,"alternative-id":["S0049384825000076"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109258","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disparities in menstrual bleeding management during acute venous thromboembolism treatment: A review of UK practice and a call for clinical studies","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109258","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109258"}}